Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
18.07
+0.19 (1.06%)
At close: Mar 9, 2026, 4:00 PM EDT
18.14
+0.07 (0.39%)
After-hours: Mar 9, 2026, 7:51 PM EDT
Takeda Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Market Capitalization | 56,106 | 45,074 | 43,399 | 50,869 | 44,662 | 56,329 | |
| Market Cap Growth | 27.69% | 3.86% | -14.68% | 13.90% | -20.71% | 17.61% | |
| Enterprise Value | 86,256 | 78,050 | 75,918 | 81,755 | 74,563 | 98,218 | |
| Last Close Price | 18.07 | 14.61 | 13.15 | 15.10 | 12.65 | 15.51 | |
| PE Ratio | 77.90 | 62.54 | 45.57 | 21.33 | 23.57 | 16.57 | |
| PS Ratio | 1.97 | 1.47 | 1.54 | 1.68 | 1.52 | 1.95 | |
| PB Ratio | 1.15 | 0.97 | 0.90 | 1.06 | 0.95 | 1.20 | |
| P/FCF Ratio | 8.76 | 7.88 | 12.14 | 8.08 | 5.42 | 6.92 | |
| P/OCF Ratio | 7.40 | 6.39 | 9.16 | 6.92 | 4.83 | 6.16 | |
| EV/Sales Ratio | 3.03 | 2.55 | 2.69 | 2.70 | 2.54 | 3.40 | |
| EV/EBITDA Ratio | 10.62 | 9.48 | 10.04 | 8.46 | 7.65 | 11.04 | |
| EV/EBIT Ratio | 22.42 | 20.76 | 22.99 | 17.54 | 15.09 | 25.62 | |
| EV/FCF Ratio | 13.47 | 13.65 | 21.23 | 12.99 | 9.06 | 12.07 | |
| Debt / Equity Ratio | 0.71 | 0.73 | 0.75 | 0.77 | 0.85 | 0.98 | |
| Debt / EBITDA Ratio | 4.09 | 3.96 | 4.57 | 3.79 | 4.07 | 5.16 | |
| Debt / FCF Ratio | 5.37 | 5.94 | 10.10 | 5.81 | 4.81 | 5.64 | |
| Net Debt / Equity Ratio | 0.62 | 0.68 | 0.69 | 0.68 | 0.70 | 0.79 | |
| Net Debt / EBITDA Ratio | 3.74 | 3.81 | 4.38 | 3.37 | 3.35 | 4.17 | |
| Net Debt / FCF Ratio | 4.72 | 5.49 | 9.25 | 5.17 | 3.96 | 4.56 | |
| Asset Turnover | 0.29 | 0.31 | 0.29 | 0.30 | 0.27 | 0.25 | |
| Inventory Turnover | 1.16 | 1.30 | 1.30 | 1.36 | 1.40 | 1.34 | |
| Quick Ratio | 0.54 | 0.44 | 0.50 | 0.49 | 0.73 | 1.00 | |
| Current Ratio | 1.19 | 1.01 | 1.11 | 0.97 | 1.21 | 1.53 | |
| Return on Equity (ROE) | 1.50% | 1.52% | 2.12% | 5.27% | 4.24% | 7.60% | |
| Return on Assets (ROA) | 2.47% | 2.40% | 2.15% | 2.85% | 2.88% | 2.06% | |
| Return on Invested Capital (ROIC) | 2.76% | 2.91% | 4.35% | 5.15% | 4.82% | 4.50% | |
| Return on Capital Employed (ROCE) | 4.70% | 4.80% | 3.90% | 5.40% | 5.40% | 3.80% | |
| Earnings Yield | 1.28% | 1.60% | 2.20% | 4.69% | 4.24% | 6.04% | |
| FCF Yield | 11.41% | 12.69% | 8.24% | 12.37% | 18.44% | 14.44% | |
| Dividend Yield | 2.92% | 8.96% | 9.45% | 8.97% | 11.72% | 10.49% | |
| Payout Ratio | 117.40% | 280.28% | 199.34% | 88.14% | 123.30% | 75.36% | |
| Buyback Yield / Dilution | -0.25% | -1.58% | -0.67% | 0.46% | -0.23% | -0.47% | |
| Total Shareholder Return | 2.67% | 7.38% | 8.78% | 9.43% | 11.49% | 10.02% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.